These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 25577268)
21. Detection and prognostic analysis of serum protein expression in esophageal squamous cell cancer. Jiang H; Wang XH; Yu XM; Zheng ZG Asian Pac J Cancer Prev; 2012; 13(4):1579-82. PubMed ID: 22799370 [TBL] [Abstract][Full Text] [Related]
22. Serum albumin-bound proteomic signature for early detection and staging of hepatocarcinoma: sample variability and data classification. Camaggi CM; Zavatto E; Gramantieri L; Camaggi V; Strocchi E; Righini R; Merina L; Chieco P; Bolondi L Clin Chem Lab Med; 2010 Sep; 48(9):1319-26. PubMed ID: 20509833 [TBL] [Abstract][Full Text] [Related]
23. Serum proteomic profiling of lung cancer in high-risk groups and determination of clinical outcomes. Jacot W; Lhermitte L; Dossat N; Pujol JL; Molinari N; Daurès JP; Maudelonde T; Mangé A; Solassol J J Thorac Oncol; 2008 Aug; 3(8):840-50. PubMed ID: 18670301 [TBL] [Abstract][Full Text] [Related]
24. Detection of lung adenocarcinoma using magnetic beads based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry serum protein profiling. Lin XL; Yang SY; Du J; Tian YX; Bu LN; Huo SF; Wang FP; Nan YD Chin Med J (Engl); 2010 Jan; 123(1):34-9. PubMed ID: 20137572 [TBL] [Abstract][Full Text] [Related]
25. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry. Liu XP; Shen J; Li ZF; Yan L; Gu J Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557 [TBL] [Abstract][Full Text] [Related]
26. Angiopoietin-Like Protein 2 Acts as a Novel Biomarker for Diagnosis and Prognosis in Patients with Esophageal Cancer. Ide S; Toiyama Y; Shimura T; Kawamura M; Yasuda H; Saigusa S; Ohi M; Tanaka K; Mohri Y; Kusunoki M Ann Surg Oncol; 2015 Aug; 22(8):2585-92. PubMed ID: 25564164 [TBL] [Abstract][Full Text] [Related]
27. Proteomic identification of salivary transferrin as a biomarker for early detection of oral cancer. Jou YJ; Lin CD; Lai CH; Chen CH; Kao JY; Chen SY; Tsai MH; Huang SH; Lin CW Anal Chim Acta; 2010 Nov; 681(1-2):41-8. PubMed ID: 21035601 [TBL] [Abstract][Full Text] [Related]
28. Oral cancer plasma tumor marker identified with bead-based affinity-fractionated proteomic technology. Cheng AJ; Chen LC; Chien KY; Chen YJ; Chang JT; Wang HM; Liao CT; Chen IH Clin Chem; 2005 Dec; 51(12):2236-44. PubMed ID: 16239339 [TBL] [Abstract][Full Text] [Related]
29. Mass spectrometry protein expression profiles in colorectal cancer tissue associated with clinico-pathological features of disease. Liao CC; Ward N; Marsh S; Arulampalam T; Norton JD BMC Cancer; 2010 Aug; 10():410. PubMed ID: 20691062 [TBL] [Abstract][Full Text] [Related]
30. New serum biomarkers for detection of endometriosis using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Zheng N; Pan C; Liu W J Int Med Res; 2011; 39(4):1184-92. PubMed ID: 21986120 [TBL] [Abstract][Full Text] [Related]
31. Elevated serum synuclein-gamma in patients with gastrointestinal and esophageal carcinomas. Liu C; Ma H; Qu L; Wu J; Meng L; Shou C Hepatogastroenterology; 2012 Oct; 59(119):2222-7. PubMed ID: 22440249 [TBL] [Abstract][Full Text] [Related]
32. An expression of squamous cell carcinoma antigen 2 in peripheral blood within the different stages of esophageal carcinogenesis. Yang YF; Li H; Xu XQ; Diao YT; Fang XQ; Wang Y; Zhao DL; Wu K; Li HQ Dis Esophagus; 2008; 21(5):395-401. PubMed ID: 19125792 [TBL] [Abstract][Full Text] [Related]
33. Proteomic identification of alpha-2-HS-glycoprotein as a plasma biomarker of hypopharyngeal squamous cell carcinoma. Tian WD; Li JZ; Hu SW; Peng XW; Li G; Liu X; Chen HH; Xu X; Li XP Int J Clin Exp Pathol; 2015; 8(8):9021-31. PubMed ID: 26464644 [TBL] [Abstract][Full Text] [Related]
34. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596 [TBL] [Abstract][Full Text] [Related]
35. Comparison of peptide cancer signatures identified by mass spectrometry in serum of patients with head and neck, lung and colorectal cancers: association with tumor progression. Pietrowska M; Polańska J; Suwiński R; Wideł M; Rutkowski T; Marczyk M; Domińczyk I; Ponge L; Marczak L; Polański A; Widłak P Int J Oncol; 2012 Jan; 40(1):148-56. PubMed ID: 21894432 [TBL] [Abstract][Full Text] [Related]
36. New potential biomarkers in the diagnosis of esophageal squamous cell carcinoma. Xu SY; Liu Z; Ma WJ; Sheyhidin I; Zheng ST; Lu XM Biomarkers; 2009 Aug; 14(5):340-6. PubMed ID: 19552569 [TBL] [Abstract][Full Text] [Related]
37. Principle component analysis combined with matrix-assisted laser desorption ionization mass spectrometry for rapid diagnosing the sera of patients with major depression. Huang TL; Cho YT; Su H; Shiea J Clin Chim Acta; 2013 Sep; 424():175-81. PubMed ID: 23778025 [TBL] [Abstract][Full Text] [Related]
38. Potential plasma biomarkers of bladder cancer identified by proteomic analysis: A pilot study. Lemańska-Perek A; Lis-Kuberka J; Lepczyński A; Dratwa-Chałupnik A; Tupikowski K; Kątnik-Prastowska I; Ożgo M Adv Clin Exp Med; 2019 Mar; 28(3):339-346. PubMed ID: 29963784 [TBL] [Abstract][Full Text] [Related]
39. Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform. Pan S; Rush J; Peskind ER; Galasko D; Chung K; Quinn J; Jankovic J; Leverenz JB; Zabetian C; Pan C; Wang Y; Oh JH; Gao J; Zhang J; Montine T; Zhang J J Proteome Res; 2008 Feb; 7(2):720-30. PubMed ID: 18186601 [TBL] [Abstract][Full Text] [Related]
40. Classification of Epidermal Growth Factor Receptor Gene Mutation Status Using Serum Proteomic Profiling Predicts Tumor Response in Patients with Stage IIIB or IV Non-Small-Cell Lung Cancer. Yang L; Tang C; Xu B; Wang W; Li J; Li X; Qin H; Gao H; He K; Song S; Liu X PLoS One; 2015; 10(6):e0128970. PubMed ID: 26047516 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]